Table 2.

Clinical Characteristics of Insulin Autoimmune Syndrome (IAS) Cases Reported in the United States

Patient	Age	Gender	Ethnicity	Associated Conditions/Medications	Reference
1	63	M	Caucasian	Multiple myeloma	18
2	16	M	African-American	Methimazole	19
3	67	M	Caucasian	Chronic myelomonocytic leukemia	6
4	71	M	Caucasian	–	6
5	80	F	–	–	20
6	73	F	Caucasian	Systemic lupus erythematosus	21
7	61	M	Caucasian	Ulcerative colitis	21
8	46	F	Caucasian	–	21
9	64	F	Caucasian	–	21
10	84	F	Caucasian	–	21
11	75	F	Caucasian	Propylthiouracil	21
12	72	F	Caucasian	–	21
13	77	M	Caucasian	–	22
14	55	M	Caucasian	Alcoholic cirrhosis, acquired inhibitors to factor V	23
15	74	M	African-American	Hydralazine	24
16	73	M	–	Multiple myeloma	25
17	52	F	Caucasian	Rheumatoid arthritis, penicillamine	26
18	33	M	Caucasian	Rheumatoid arthritis, penicillamine	26
19	61	F	Caucasian	Rheumatoid arthritis, penicillamine	11
20	82	F	Caucasian	Drug-induced lupus erythematosus (hydralazine, procainamide)	27
21	58	F	Caucasian	Rheumatoid arthritis	28
22	43	F	Latin-American (Honduran)	–	28
23	10 month	M	–	–	28
24	26	F	Caucasian	Pregnancy	28
25	48	F	Caucasian	–	28